Literature DB >> 567935

Plasmalogenase is elevated in early demyelinating lesions.

L A Horrocks, S Spanner, R Mozzi, S C Fu, R A D'Amato, S Krakowka.   

Abstract

Plasmalogenase catalyzes the hydrolysis of ethanolamine plasmalogens to long-chain aldehydes and 2-acyl-sn-glycero-3-phosphoethanolamines. During development, plasmalogenase activity parallels myelination. The enzyme is most concentrated within oligodendroglial cells and is absent from myelin. The normal function of plasmalogenase in white matter may be related to its specificity for plasmalogens that contain most of the thromboxane and prostaglandin precursors. Plasmalogenase activities are elevated in demyelinating CNS tissues including canine white matter with lesions due to distemper virus. Elevated plasmalogenase activity precedes cellular invasion and lysosomal activation as indicated by beta-glucuronidase, acid proteinase and neutral proteinase activities. The elevation of plasmalogenase activity was 4.9-fold greater than normal in an early demyelinating lesion caused by the Snyder-Hill strain of distemper virus. Phospholipases acting on phosphatidyl ethanolamine were not activated in this tissue and have activities much lower than plasmalogenase in control tissues. Plasmalogenase activities are also elevated after intracerebral injections of complement-dependent anti-myelin antibody and after ischemia. Plasmalogenase acting on the oligodendrocyte plasma membrane may be responsible for necrosis of the oligodendrocyte that results in demyelination.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567935     DOI: 10.1007/978-1-4684-2514-7_30

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids.

Authors:  A A Farooqui; L Liss; L A Horrocks
Journal:  Metab Brain Dis       Date:  1988-03       Impact factor: 3.584

3.  Neural membrane phospholipids in Alzheimer disease.

Authors:  K Wells; A A Farooqui; L Liss; L A Horrocks
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

4.  Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.

Authors:  J M Boggs; D Stamp; M A Moscarello
Journal:  Neurochem Res       Date:  1982-08       Impact factor: 3.996

5.  Plasmalogenase and phospholipase A1, A2, and L1 activities in white matter in canine distemper virus-associated demyelinating encephalomyelitis.

Authors:  S C Fu; R Mozzi; S Krakowka; R J Higgins; L A Horrocks
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

6.  The role of phospholipases from inflammatory macrophages in demyelination.

Authors:  J Trotter; M E Smith
Journal:  Neurochem Res       Date:  1986-03       Impact factor: 3.996

Review 7.  Regulation of plasmalogen metabolism and traffic in mammals: The fog begins to lift.

Authors:  Fabian Dorninger; Ernst R Werner; Johannes Berger; Katrin Watschinger
Journal:  Front Cell Dev Biol       Date:  2022-08-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.